TOPIC

/ company

Fosun Group

Fosun International (Hong Kong stock code 00656.HK), the parent of Fosun Group, listed in Hong Kong in July 2007. Fosun Group said it mainly invests in sectors that will significantly benefit from growth in China’s domestic demand, such as consumption, financial services, resources and energy, and manufacturing.

Chairman / President

Guo Guangchang

CEO / Managing Director

Xu Xiaoliang

CFO / Finance Director

Xu Xiaoliang

Industry

Conglomerate

Website

fosun.com

Headquarters address

Room 808, ICBC Tower, 3 Garden Road, Central, Hong Kong

Stock Code

SEHK:00656

Year founded

1992

Shanghai Fosun Pharmaceutical

Fosun turns page after property writedowns, shifts focus back to growth

Profit attributable to shareholders rose 160 per cent to 1.72 billion yuan in the six months through June.

27 Aug 2026 - 9:05PM

Hong Kong

Will Fosun’s luxury project revive Hong Kong’s Movietown magic?

29 Jun 2026 - 7:55PM

Tourism

What is China’s luxury Silk Road Express train like? We ride its new route

12 May 2026 - 7:15AM

China Conference: Southeast Asia

Fosun Health to build first overseas hospitals in Indonesia amid global push

The Chinese healthcare group is also exploring opportunities to work with local distributors to sell its products in Indonesia.

11 Feb 2026 - 7:11PM

Hu Hang, CEO of Fosun Health Group, speaking at the China Conference: Southeast Asia 2026, on Tuesday. Photo: SCMP

Cryptocurrency

Consensus 2026 kicks off in Hong Kong amid tighter Beijing oversight

Organised by CoinDesk, the event is an important gathering for digital finance and cryptocurrency professionals.

11 Feb 2026 - 9:00AM

Malaysia

Cold spots are hot tickets as southern Chinese head north to ski

Ski resorts record big visitor increases as high-speed rail and flight expansions bring in those who have tried the sport in indoor venues.

14 Dec 2025 - 12:30PM

China’s private sector

Fosun brings UK particle therapy to mainland China in advanced cancer care push

The US Food and Drug Administration-approved Marie system promises human-centred care, advanced technology and lower costs.

7 Nov 2025 - 7:30AM

Fosun Pharmaceutical says the Marie system could reduce total treatment costs by 50 per cent compared with existing therapies. Photo: Daniel Ren

Greater Bay Area

Greater Bay Area hospitals bet resort-like services will pull in global visitors

As Macau diversifies beyond gaming, wellness clinics are emerging as the next big pillar of the Greater Bay Area’s economy.

25 Oct 2025 - 10:47AM

Greater Bay Area

Unmet healthcare demand in Asia presents Chinese hospitals with opportunities

Fosun Health is targeting medical tourists from South Asia, Southeast Asia and the Middle East, CEO Frank Hu Hang says.

21 Oct 2025 - 2:53PM

Banking & finance

China’s brokerages told to pause RWA tokenisation business in Hong Kong: sources

Two brokerages were advised by the CSRC in recent weeks to refrain from conducting RWA business offshore, the sources said.

23 Sep 2025 - 3:37PMvideocam

Hong Kong over the past year has ramped up efforts to position the city as a digital assets hub. Photo: Shutterstock

Fintech

Jack Ma-backed Yunfeng names ex-Ant Group executive as top Web3 architect

Yunfeng’s appointment of Geoff Jiang Guofei reflects the company’s push into what it called ‘frontier areas’ such as Web3.

18 Sep 2025 - 7:00PM

Yunfeng Financial Group recently completed its first tokenised real-world asset project. Photo: Handout

New medical drugs

Fosun’s Henlius in talks with Johnson & Johnson, Roche on cancer drug

Shanghai Henlius Biotech is in talks with multinational pharmaceutical firms about selling them the rights to an experimental cancer drug.

16 Sep 2025 - 4:30PM

Blockchain

Fosun drives Hong Kong stock performance-linked tokens on blockchains

This initiative ‘shows where the future of capital markets is heading’, the CEO of Fosun partner Vaulta says.

5 Sep 2025 - 7:05PM

Hong Kong politics

Editorial | Mideast mission led by Lee highlights city role in national push

Hong Kong shows its strength as a ‘superconnector’ by reaching dozens of deals for city and mainland China concerns with Qatar and Kuwait.

15 May 2025 - 6:30AM

Hong Kong leader John Lee (left) with Qatari Minister of Labour Ali bin Saeed bin Samikh Al Marri on May 12. Photo: Handout

Health in China

Chinese pharmaceutical companies look abroad for growth markets

Shanghai Henlius struck a deal in Saudi Arabia while XtalPi signed a partnership with Sinar Mas Multiartha in Indonesia.

11 Nov 2024 - 7:01PM

Fosun’s Shanghai Henlius, Tecent-backed XtalPi ink partnership deals with Asian partners. Photo: Shanghai Henlius

Mergers & Acquisitions

China’s Fosun in talks to sell stake in Club Med to Singapore’s CapitaLand

The firm, part of Temasek Holdings-owned conglomerate CapitaLand Group, seeks to acquire from 20 to 30 per cent of the hotelier.

17 Sep 2024 - 4:52PM

Hong Kong stock market

Club Med owner bets on winter sports in China amid skiing craze

‘Tourist attractions featuring snow and ice will be our major growth engine,’ says Fosun Tourism co-president Andrew Xu.

25 Aug 2024 - 2:30PM

Hong Kong stock market

Shanghai biotech firm’s shares soar after Fosun’s US$690 million buyout offer

Henlius joins a wave of companies that have left Hong Kong’s stock market this year, either through privatisation or voluntary delisting having found themselves undervalued.

25 Jun 2024 - 5:20PMvideocam

Phosun Pharma will pay a premium of 36.7 per cent over Monday’s closing price of HK$18 for Henlius. Photo: Reuters

Mergers & Acquisitions

China’s Fosun International sells German private bank HAL to ABN Amro

The company, one of China’s largest private-sector conglomerates, aims to cut its debts by 10 billion yuan (US$1.38 billion) annually in the next two to three years.

28 May 2024 - 6:06PM

Hong Kong

US law firm Mayer Brown to split its Hong Kong operations

Mayer Brown’s Hong Kong partners plan to reestablish their firm as Johnson Stokes & Master, which was the name of the Hong Kong-based entity that merged with Mayer Brown in 2008.

3 May 2024 - 10:24AM

Insurance

China’s Fosun sells stake in Belgian insurer Ageas to BNP Paribas

More divestments to come, analyst says, as conglomerate aims to cut debts by US$1.38 billion annually in the next two to three years.

15 Apr 2024 - 6:00PM

Banking & finance

Chinese conglomerate Fosun dumps noncore assets, deleverages to boost financial profile

Chinese conglomerate Fosun International is rapidly offloading assets as it looks to lower debt and concentrate on sustainable businesses

28 Mar 2024 - 3:46PM

General view of recreational facilities located in front of Atlantis Sanya hotel in Sanya, Hainan province, China April 26, 2018. Photo: Reuters

China property

Fosun unit courts investors days after reports of debt woes at parent firm

Fosun Tourism Group, the leisure and tourism unit of Chinese conglomerate Fosun International, is courting both domestic and international investors in a move that is in line with its asset-light strategy.

15 Mar 2024 - 8:15PMvideocam